U
ARNA

UBS’s Arena Pharmaceuticals Inc ARNA Stock Holding History

UBS’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.55M Buy
36,940
+36,350
+6,161% +$1.62M ﹤0.01% 3154
2014
Q2 		$35K Sell
590
-2,360
-80% -$149K ﹤0.01% 7363
2014
Q1 		$186K Sell
2,950
-11,420
-79% -$758K ﹤0.01% 5273
2013
Q4 		$841K Sell
14,370
-40
-0.3% -$2.09K ﹤0.01% 3729
2013
Q3 		$759K Sell
14,410
-510
-3% -$34.2K ﹤0.01% 3664
2013
Q2 		$1.15M Buy
+14,920
New +$1.22M ﹤0.01% 3174

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS's ARNA Position: Q3 2014 in Review

UBS increased its Arena Pharmaceuticals Inc (ARNA) stake by 180% in Q3 2014, buying an estimated $267K and bringing the position to 9,300 shares worth $390K. The position accounts for ﹤0.01% of the portfolio, ranked #4517.

UBS first reported a position in ARNA in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.57M in Q2 2013. 121 funds tracked by Wall St. Rank hold ARNA as of Q3 2014.

  • UBS held 9,300 shares of Arena Pharmaceuticals Inc worth $390K as of Q3 2014.
  • UBS bought 5,980 Arena Pharmaceuticals Inc shares in Q3 2014, an estimated $267K.
  • Arena Pharmaceuticals Inc made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4517 holding.
  • UBS first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and has held it in 6 quarters since.
  • UBS's Arena Pharmaceuticals Inc position peaked at $1.57M in Q2 2013.
  • 121 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.